000 01656 a2200481 4500
005 20250514215030.0
264 0 _c20050418
008 200504s 0 0 eng d
022 _a0261-4189
024 7 _a10.1038/sj.emboj.7600539
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDragoi, Ana-Maria
245 0 0 _aDNA-PKcs, but not TLR9, is required for activation of Akt by CpG-DNA.
_h[electronic resource]
260 _bThe EMBO journal
_cFeb 2005
300 _a779-89 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aActive Transport, Cell Nucleus
_xdrug effects
650 0 4 _aAnimals
650 0 4 _aBone Marrow
_xdrug effects
650 0 4 _aCells, Cultured
650 0 4 _aDNA-Activated Protein Kinase
650 0 4 _aDNA-Binding Proteins
_xmetabolism
650 0 4 _aEnzyme Activation
650 0 4 _aMacrophages
_xdrug effects
650 0 4 _aMice
650 0 4 _aMice, Knockout
650 0 4 _aOligodeoxyribonucleotides
_xpharmacology
650 0 4 _aPhosphorylation
650 0 4 _aProtein Serine-Threonine Kinases
_xmetabolism
650 0 4 _aProto-Oncogene Proteins
_xmetabolism
650 0 4 _aProto-Oncogene Proteins c-akt
650 0 4 _aReceptors, Cell Surface
_xmetabolism
650 0 4 _aToll-Like Receptor 9
700 1 _aFu, Xiaoying
700 1 _aIvanov, Stanimir
700 1 _aZhang, Ping
700 1 _aSheng, Linbo
700 1 _aWu, Dianqing
700 1 _aLi, Gloria C
700 1 _aChu, Wen-Ming
773 0 _tThe EMBO journal
_gvol. 24
_gno. 4
_gp. 779-89
856 4 0 _uhttps://doi.org/10.1038/sj.emboj.7600539
_zAvailable from publisher's website
999 _c15355921
_d15355921